Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc reports results for the quarter ended in September - Earnings Summary

* Bioatla Inc  BCAB.OQ  reported a quarterly adjusted loss
of 69
cents​​ per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 80 cents per share.
    * Reported revenue was zero​; analysts expected $466.67
thousand. 
    * Bioatla Inc's reported EPS for the quarter was a loss
of 69
cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bioatla Inc shares had fallen by 17.4% this quarter and
lost 67.6% so far this year.
    * The company reported a quarterly loss of $25.78 million.
    * Wall Street's median 12-month price target for Bioatla Inc
is
$22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
4 at 10:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.80          -0.69          Beat
 Jun. 30 2022      -0.69          -0.77          Missed
 Mar. 31 2022      -0.67          -0.65          Beat
 Dec. 31 2021      -0.63          -0.62          Beat

Recent news on Bioatla

See all news